- Sector
- Healthcare
- IPO Date
- Oct 29, 2021
Highlights
- Market Cap
- $15.28M
- Enterprise Value
- $17.19M
- EPS (TTM)
- -$0.97
- Total Revenue (TTM)
- $43.20M
- Gross Profit (TTM)
- $35.77M
- EBITDA (TTM)
- -$8.27M
- Year Range
- $0.02 - $0.19
- ROA (TTM)
- -44.72%
- ROE (TTM)
- -182.62%
- Avg. Volume (1M)
- 5K
- Avg. Volume Value (1M)
- $142.59
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
BFRIW Performance Chart
Biofrontera Inc. Warrants (BFRIW) is down 66.7% since the beginning of the year. At $0 per share, BFRIW is trading 84.2% below its 52-week high of $0.
Loading charts...
Compare this symbol against anything
Returns By Period
Biofrontera Inc. Warrants (BFRIW) has returned -66.67% so far this year and -80.00% over the past 12 months.
Biofrontera Inc. Warrants
- 1D
- 0.00%
- 1M
- 11.94%
- 6M
- -40.00%
- YTD
- -66.67%
- 1Y
- -80.00%
- 3Y*
- -26.35%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -48.61%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
BFRIW Monthly Returns History
Based on dividend-adjusted daily data since Oct 29, 2021, BFRIW's average daily return is +1.96%, while the average monthly return is +15.36%. At this rate, an investment would double in approximately 0.4 years.
Historically, 38% of months were positive and 62% were negative. The best month was Feb 2024 with a return of +557.9%, while the worst month was Jan 2022 at -66.7%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 9 months.
On a daily basis, BFRIW closed higher 26% of trading days. The best single day was Oct 31, 2024 with a return of +386.7%, while the worst single day was Nov 1, 2024 at -65.3%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -44.44% | 35.80% | -40.65% | -25.31% | -24.92% | 19.03% | 11.52% | -66.67% | |||||
| 2025 | -1.15% | 66.50% | -39.74% | -33.72% | 130.58% | 14.24% | 42.72% | -9.47% | -23.35% | -6.71% | -47.06% | 75.10% | 48.27% |
| 2024 | -24.00% | 557.89% | 35.20% | -11.24% | -0.08% | -36.40% | -21.32% | 50.00% | -33.33% | 532.67% | -31.51% | -53.31% | 507.00% |
| 2023 | 10.44% | 21.57% | -9.26% | 24.08% | -60.49% | -8.41% | -9.27% | -59.82% | -2.74% | -23.33% | -62.54% | -10.71% | -95.03% |
| 2022 | -66.67% | 10.83% | 9.77% | -9.59% | -20.45% | -32.38% | -7.75% | 6.87% | -14.29% | 6.67% | -25.80% | -57.65% | -94.41% |
| 2021 | 81.69% | 48.84% | 87.50% | 407.04% |
Benchmark Metrics
Biofrontera Inc. Warrants has an annualized alpha of 14481.78%, beta of -0.76, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since October 29, 2021.
- This stock participated in 177.73% of S&P 500 Index downside but only -63.28% of its upside - more exposed to losses than it benefited from rallies.
- Beta of -0.76 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 14,481.78%
- Beta
- -0.76
- R²
- 0.00
- Upside Capture
- -63.28%
- Downside Capture
- 177.73%
Return for Risk
Risk / Return Rank
BFRIW ranks 33 for risk / return — above 33% of stocks peers on PortfoliosLab. Its historical combined result is below the peer median.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Biofrontera Inc. Warrants (BFRIW) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BFRIW | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.74 | ||
| Sortino ratioReturn per unit of downside risk | -1.09 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.25 | -0.11 |
| Calmar ratioReturn relative to maximum drawdown | -0.92 | 2.00 | -2.93 |
| Martin ratioReturn relative to average drawdown | -1.30 | 8.49 | -9.80 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Biofrontera Inc. Warrants. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Biofrontera Inc. Warrants was 99.91%, occurring on Jan 23, 2024. The portfolio has not yet recovered.
The current Biofrontera Inc. Warrants drawdown is 99.62%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-99.91%Jan 2024 | 2y 27d | — | 4y 7moDec 2021 - now | — |
-62.62%Dec 2021 | 8d | 14d | 22dNov 2021 - Dec 2021 | — |
-44.95%Nov 2021 | 22d | 3d | 25dNov 2021 - Nov 2021 | — |
-9.15%Dec 2021 | 1d | 1d | 1dDec 2021 - Dec 2021 | — |
Drawdown Indicators
| BFRIW | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.91% | -56.78% | -43.13% |
Max Drawdown (1Y)Largest decline over 1 year | -86.87% | -9.10% | -77.77% |
Max Drawdown (3Y)Largest decline over 3 years | -92.48% | -18.90% | -73.58% |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -99.62% | -1.58% | -98.04% |
Average DrawdownAverage peak-to-trough decline | -94.37% | -10.70% | -83.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 66.11% | 2.14% | +63.97% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Biofrontera Inc. Warrants over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Biofrontera Inc. Warrants is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for BFRIW relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, BFRIW has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for BFRIW in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, BFRIW has a P/B value of 0.1. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with BFRIW
Add Biofrontera Inc. Warrants to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with BFRIW